Forkhead box M1 (FOXM1), which along with AURKA is a co‐predictor of prognosis and sorafenib efficacy in HCC, regulates AURKA at the promoter level resulting in increased self‐renewal capacity of breast cancer stem cells.74, 107. The gene discussed is AURKA; the disease is breast carcinoma.